Dermatology

Narin Apisarnthanarax

Accepts Medicare (pay less out of pocket)

Group Affiliations

CLEAR LAKE DERMATOLOGY PLLC

Address

13938 Hwy 3,

Unit 100,

Webster 77598-1622, TX

Phone

(281) 332-9681

Details

Specialty

Dermatology

Gender

M

Medical School

University Of Texas Medical Branch At Galveston

Graduation Year

1998

Offers Telehealth Services

No

Accepts Medicare Assignment

Yes

Facility / Group Affiliations

Facility Type

Group

Group Name

CLEAR LAKE DERMATOLOGY PLLC

Member Count

5

Accepts Medicare Assignment

Y

Quality Payment Program (QPP) Performance

MIPS Measure

Improved Practices that Engage Patients Pre-Visit

Attestation

Yes

MIPS Measure

Regularly assess the patient experience of care through surveys, advisory councils and/or other mechanisms.

Attestation

Yes

MIPS Measure

Drug Cost Transparency

Attestation

Yes

MIPS Measure

Improved Practices that Disseminate Appropriate Self-Management Materials

Attestation

Yes

MIPS Measure

Engagement of Patients, Family, and Caregivers in Developing a Plan of Care

Attestation

Yes

MIPS Measure

Financial Navigation Program

Attestation

Yes

MIPS Measure

Engagement of patients through implementation of improvements in patient portal

Attestation

Yes

MIPS Measure

Collection and follow-up on patient experience and satisfaction data on beneficiary engagement

Attestation

Yes

MIPS Measure

Tobacco use

Attestation

Yes

MIPS Measure

Implementation of Use of Specialist Reports Back to Referring Clinician or Group to Close Referral Loop

Attestation

Yes

MIPS Measure

Regular training in care coordination

Attestation

Yes

MIPS Measure

Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record

Attestation

Yes

MIPS Measure

Implementation of improvements that contribute to more timely communication of test results

Attestation

Yes

MIPS Measure

Implementation of documentation improvements for practice/process improvements

Attestation

Yes

MIPS Measure

Collection and use of patient experience and satisfaction data on access

Attestation

Yes

MIPS Measure

Implementation of medication management practice improvements

Attestation

Yes

MIPS Measure

Use of decision support and standardized treatment protocols

Attestation

Yes

MIPS Measure

Advance Care Plan

Attestation

No

MIPS Measure

Pneumococcal Vaccination Status for Older Adults

Attestation

No

MIPS Measure

Documentation of Current Medications in the Medical Record

Attestation

No

MIPS Measure

Melanoma: Continuity of Care Recall System

Attestation

No

MIPS Measure

Psoriasis: Tuberculosis (TB) Prevention for Patients with Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis on a Biological Immune Response Modifier

Attestation

No

MIPS Measure

Immunizations for Adolescents

Attestation

No

MIPS Measure

Immunizations for Adolescents

Attestation

No

MIPS Measure

Immunizations for Adolescents

Attestation

No

MIPS Measure

Psoriasis: Clinical Response to Systemic Medications

Attestation

No

MIPS Measure

Immunizations for Adolescents

Attestation

No

MIPS Measure

e-Prescribing

Attestation

No

MIPS Measure

Support Electronic Referral Loops By Receiving and Reconciling Health Information Exclusion

Attestation

Yes

MIPS Measure

Support Electronic Referral Loops By Sending Health Information Exclusion

Attestation

Yes

MIPS Measure

ONC Direct Review Attestation

Attestation

Yes

MIPS Measure

Provide Patients Electronic Access to Their Health Information

Attestation

No

MIPS Measure

Clinical Data Registry Reporting

Attestation

Yes

MIPS Measure

Clinical Data Registry Reporting for Multiple Registry Engagement

Attestation

Yes

MIPS Measure

Security Risk Analysis

Attestation

Yes

Clinician Utilization Performance Scores

Tangential biopsy of single skin lesion

Practice State: TX

Line Service Count: 205

Beneficiary Count: 170

Tangential biopsy of additional skin lesion

Practice State: TX

Line Service Count: 46

Beneficiary Count: 33

Repair of wound (2.6 to 7.5 centimeters) of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, and/or feet

Practice State: TX

Line Service Count: 20

Beneficiary Count: 17

Destruction of skin growth

Practice State: TX

Line Service Count: 458

Beneficiary Count: 333

Destruction of 2-14 skin growths

Practice State: TX

Line Service Count: 2139

Beneficiary Count: 280

Destruction of up to 14 skin growths

Practice State: TX

Line Service Count: 375

Beneficiary Count: 309

Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks)

Practice State: TX

Line Service Count: 91

Beneficiary Count: 71

Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals

Practice State: TX

Line Service Count: 43

Beneficiary Count: 28

Removal and microscopic examination of growth of the trunk, arms, or legs (first stage, up to 5 tissue blocks)

Practice State: TX

Line Service Count: 32

Beneficiary Count: 29

Pathology examination of tissue using a microscope, intermediate complexity

Practice State: TX

Line Service Count: 214

Beneficiary Count: 134

Injection, triamcinolone acetonide, not otherwise specified, 10 mg

Practice State: TX

Line Service Count: 33

Beneficiary Count: 22

Locations

13938 Hwy 3
Unit 100
Webster, TX 77598 -1622
Phone: (281) 332-9681

Get Directions